Orthofix gets FDA clearance and CE Mark for its limb preservation solution
Source: SeekingAlpha
2025-03-19 10:13:02 ET
More on Orthofix Medical Inc.
- Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript
- Orthofix Medical Inc. 2024 Q4 - Results - Earnings Call Presentation
- Orthofix Medical Inc. GAAP EPS of -$0.75 misses by $0.52, revenue of $215.7M beats by $2.98M
- Seeking Alpha’s Quant Rating on Orthofix Medical Inc.
- Historical earnings data for Orthofix Medical Inc.
Read the full article on Seeking Alpha
For further details see:
Orthofix gets FDA clearance and CE Mark for its limb preservation solution
Orthofix Medical Inc.
NASDAQ: OFIX
OFIX Trading
-3.03% G/L:
$12.17 Last:
107,664 Volume:
$12.43 Open:
OFIX Latest News
March 11, 2026 12:31:00 pm
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights
March 11, 2026 12:00:00 pm
OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical Inc. - OFIX
OFIX Stock Data
$534,199,400
39,084,863
0.55%
48
N/A
Medical Equipment & Supplies
Healthcare
US
Lewisville
